Windlas Biotech Ltd
BSE: 543329
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q4 FY2026 | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 |
|---|---|---|---|---|---|---|---|
| INCOME | |||||||
| Revenue | 238.50+2.3% | 233.10+4.8% | 222.40+5.9% | 210.09+3.6% | 202.71+3.9% | 195.02+4.3% | 187.00 |
| Other Income | 4.40-2.7% | 4.52+24.1% | 3.65-30.4% | 5.24+6.0% | 4.94+32.4% | 3.73-22.9% | 4.84 |
| Total Income | 242.90+2.2% | 237.62+5.1% | 226.04+5.0% | 215.33+3.7% | 207.65+4.5% | 198.75+3.6% | 191.84 |
| EXPENSES | |||||||
| Expenditure | 222.74+2.3% | 217.70+7.5% | 202.46+5.4% | 192.07+2.8% | 186.82+4.5% | 178.78+4.2% | 171.56 |
| Tax | 4.15-16.6% | 4.97-14.1% | 5.79+3.5% | 5.59+23.1% | 4.54-4.2% | 4.74+2.5% | 4.63 |
| PROFIT | |||||||
| PBT | 20.16+1.2% | 19.92-15.5% | 23.59+1.4% | 23.26+11.7% | 20.83+4.3% | 19.97-1.6% | 20.29 |
| Net Profit | 16.02+7.1% | 14.95-16.0% | 17.80+0.8% | 17.66+8.5% | 16.29+6.9% | 15.23-2.8% | 15.66 |
| KEY METRICS | |||||||
| OPM % | 10.58%+0.12pp | 10.46%-2.38pp | 12.84%+0.21pp | 12.63%+0.03pp | 12.60%+8.58pp | 4.02%-0.17pp | 4.19% |
| NPM % | 6.59%+0.30pp | 6.29%-1.58pp | 7.87%-0.33pp | 8.20%+0.36pp | 7.84%+0.18pp | 7.66%-0.50pp | 8.16% |
| EPS | 7.60+7.2% | 7.09-16.4% | 8.48+0.6% | 8.43+8.5% | 7.77+6.6% | 7.29-2.7% | 7.49 |
Corporate Events
Board MeetingWINDLAS*
202621May
Board Meeting
The board meeting is scheduled to consider and approve the a…
BSE Filing ↗ Board MeetingWINDLAS*
202512Aug
Board Meeting
Consider and approve Notice of the Board Meeting, un-audited…
BSE Filing ↗ Board MeetingWINDLAS*
202420May
Board Meeting
Consider and approve the audited standalone and consolidated…
BSE Filing ↗ Board MeetingWINDLAS*
20248Feb
Board Meeting
Consider and approve un-audited standalone and consolidated …
BSE Filing ↗ Board MeetingWINDLAS*
20238Nov
Board Meeting
Consider and approve the un-audited standalone and consolida…
BSE Filing ↗ Board MeetingWINDLAS*
20238Aug
Board Meeting
Consider and approve un-audited standalone and consolidated …
BSE Filing ↗